The U.S. OTC market is often a challenging market to make predictions about. There are so many instances where companies, brands, consumers, and even regulators buck trends that there are often reasons to look at things on a case-by case basis. However, when it came to predicting the impact the economic recession of 2008-2009 would have on the industry, Kline turned to our vast historical data to make predictions.
Kline & Company has published “Nonprescription Drugs USA” for 30 consecutive years, preceded by periodic reports conducted since 1965. Based on this historical annual study, we were commissioned by our clients to undertake our assessment, entitled “Impact of Recessions on the U.S. OTC Market,” which was published in June 2009. More…
Meet Laura Mahecha at OTC National Conference on May 19 where she will be examining the latest in Rx to OTC switches.
